Literature DB >> 9414181

Gemcitabine-induced hemolytic uremic syndrome: a case report.

T Brodowicz, S Breiteneder, C Wiltschke, C C Zielinski.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9414181     DOI： 10.1093/jnci/89.24.1895

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

1.  Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohort.

Authors:  Florence Daviet; Franck Rouby; Pascale Poullin; Julie Moussi-Francès; Marion Sallée; Stéphane Burtey; Julien Mancini; Florence Duffaud; Renaud Sabatier; Bertrand Pourroy; Aurélie Grandvuillemin; Steven Grange; Véronique Frémeaux-Bacchi; Paul Coppo; Joëlle Micallef; Noémie Jourde-Chiche
Journal:  Br J Clin Pharmacol       Date:  2018-12-18       Impact factor: 4.335

2.  A case report of gemcitabine treatment for duodenal cancer: the good (a sustained response) and the bad (life threatening refractory thrombotic thrombocytopenic purpura).

Authors:  Andrew Robinson; William F Clark
Journal:  J Gastrointest Cancer       Date:  2010-03

3.  Eculizumab therapy for gemcitabine induced hemolytic uremic syndrome: case series and concise review.

Authors:  Omar Al Ustwani; James Lohr; Grace Dy; Charles Levea; Gregory Connolly; Pradeep Arora; Renuka Iyer
Journal:  J Gastrointest Oncol       Date:  2014-02

4.  Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report.

Authors:  S Serke; H Riess; H Oettle; D Huhn
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

5.  Drug-induced Thrombotic Microangiopathy Caused by Gemcitabine.

Authors:  Askari Hasan; Akriti G Jain; Huda Naim; Alvina Munaf; George Everett
Journal:  Cureus       Date:  2018-08-02
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.